ERB,They have over 200 FDA/CME approved products. They have been landing a ton of new distribution channels. They are watching their revenue, EPS, and Ebitda all taking off here. The stock is cheap IMO. When this one moves again people will wish they bought. Until then I accumulate and wait.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.